| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13D · 1 security · may seek to influence control | ||||||
|
Stoke Therapeutics, Inc.
13D/A
STOK · 86150R107
|
4.1% |
8/26/2025
Event 8/22/2025
|
||||
| Blue Horizon Enterprise Ltd | 3.6% | |||||
| Ezbon International Ltd | 0.5% | |||||
| Montrago Trustees Ltd | 4.1% | |||||
| Skorpios Trust | 4.1% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.